BMBF funded projects
Failing-Fontan is a present problem, which confronts cardiologists in the whole world. The Fontan-procedure enables children to survive with only one functioning ventricle. The treatment of this innate heart defect is individual for each patient and requires in some cases a cardiac support system.
Atrial fibrillation leads to a five-fold increase in the stroke risk. If treatment of the atrial fibrillation fails and long-term anti-coagulation carries to much risk in a patient, the stroke risks can be reduced by implanting an occluder in the left atrial appendage (LAA). In the PLAAO project, we design a personalized LAA occluder that will improve the closure of the LAA and reduce the risk to the patient.
The acute aortic valve stenosis is one of the most commonly observed heart valve diseases. Affected patients with a high operation risk are treated with transcatheter aortic valve implantation (TAVI), a minimally invasive procedure. This procedure comes with several risks. The development of a novel embolic protection device, the ProtEmbo device, is expected to minimize neurological complications during TAVI.
The PulmoStent is a multi-layer biohybrid Stent for the treatment of airway stenoses.